Study of Congenital Orofacial Clefts by Implementing Optical Genome Mapping

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorCentre Hospitalier Universitaire, Amiens

About this trial

Orofacial clefts, the most common congenital craniofacial malformations, have a complex etiology involving an interaction between genetic and environmental factors.

Chromosomal abnormalities, including structural variations, represent a major cause of human pathology. Recently, technological developments and the introduction of next-generation sequencing (NGS) technologies have revolutionized the field of medical genetics.

Optical genome mapping (OGM) is an innovative, high-resolution "long read" technique that enables the identification of all classes of chromosomal variation, consisting in the direct visualization of long, labeled DNA molecules throughout the genome. This technology is gradually becoming an essential tool for studying onco-hematology and constitutional genetic pathologies The purpose of this study is to search for structural chromosomal variants (SV) or copy number variants (CNV) not identifiable either by cytogenetic methods nor by "short read" NGS "short read, in individuals with oral-facial clefts with no genetic diagnosis.

Eligibility criteria

Qualifiers

Individuals with syndromic, complex or familial oral-facial clefts

With no established genetic diagnosis

Followed up at the Amiens-Picardie University Hospital

Disqualifiers

genetic diagnosis of oral-facial cleft

No health insurance affiliation

Patient under guardianship or curatorship, under safeguard of justice or deprived under public law

Pregnant, parturient or breast-feeding woman

Trial design

Treatments tested in this trial

  • blood withdrawal

Treatment groups

26 Participants
are divided into 1 treatment group